Quote List Quote List

Corvus Pharma(CRVS.US)

Event Tracking

Jan5

Corvus Pharmaceuticals Postpones Release of Soquelitinib's Phase 1 Clinical Trial Results for Atopic Dermatitis

13:31

Nov5

Corvus Pharma released FY2025 9 Months Earnings on November 4 After-Market EST with actual revenue of USD 0 and EPS of USD -0.3576

00:00

Corvus Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1226 (forecast USD -0.1295)

00:00

Nov4

Corvus Pharmaceuticals Reports Improved Net Loss in Q3 2025, soquelitinib Development Progresses Smoothly

21:03

Oct28

Corvus Pharma to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 0, EPS USD -0.1295

00:06

Aug7

Corvus Pharma released FY2025 Semi-Annual Earnings on August 7 After-Market (EST), Actual Revenue: USD 0, Actual EPS: USD -0.2606

23:00

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -10.16 M, EPS -0.1226

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.998 M, EPS -0.1028

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income 15.19 M, EPS -0.1322

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More